Spark Therapeutics
Pharmaceuticals
Company overview
Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. Its products include voretigene neparvovec, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or biallelic mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia. The companys products also comprise SPK-7001 that is in Phase 1/2 trial for choroideremia; SPK-9001, which is in Phase 1/2 trial for hemophilia B; and SPK-8011 that is in Phase 1/2 trial hemophilia A. In addition, its product candidates and development programs include SPK-FVIII program to treat hemophilia A; SPK-TPP1 program for the treatment of a form of Batten disease and Huntington's disease; RhoNova for the treatment of rhodopsin-linked autosomal dominant retinitis pigmentosa; and SPK-LHON for treating Leber heredit
Employees by Level
C-Level
11
VP-Level
26
Director
206
Manager
115
Non-Manager
443
Top Contacts
790
Available Jobs at Spark Therapeutics
Top C-suite Members of Company
Connect with key decision-makers at Spark Therapeutics. View the C-suite executives and leadership team.
| Name | Title | Contact | Action |
|---|---|---|---|
| Ciecie Sulli | Chief Executive Officer | c****i@sparktx.com | Show details |
| Holly Brunbeck | Senior Director Chief of Staff To the Chief P | h****k@sparktx.com | Show details |
| Arun Kejariwal | Chief Executive Officer & Chief of Staff | a****l@sparktx.com | Show details |
| Samantha Jones | Chief Legal Officer & Gc Chief of Staff & Gc | s****s@sparktx.com | Show details |
| Christopher Stevens | Executive Vice President & Patient Supply Chi | c****s@sparktx.com | Show details |
| Arun Kejariwal | Chief Executive Officer & Chief of Staff | a****l@sparktx.com | Show details |
| Christopher Stevens | Executive Vice President & Patient Supply Chi | c****s@sparktx.com | Show details |
| Keith Lange | Vice President Head of Intellectual Property | k****e@sparktx.com | Show details |
| Scott Hocking | Vice President, Sales & Market Access (US) | s****g@sparktx.com | Show details |
| Amy Sarola | Vice President, Senior Associate General Coun | a****a@sparktx.com | Show details |
| Brian Gallagher | Controller | b****r@sparktx.com | Show details |
Employees Contact
Connect with company employees using the separately sourced, masked contact dataset.
Email formats
Discover the professional email patterns used at Spark Therapeutics.
| Email format | Example | Percentage |
|---|---|---|
| Email formats for Spark Therapeutics are not available. | ||
Email verification tool
Find and verify professional email addresses for Spark Therapeutics.
Technology stack
Spark Therapeutics uses HSTS to enhance their digital capabilities and improve operational efficiency.
Spark Therapeutics uses Amazon CloudFront to securely deliver content, APIs, and applications globally with low latency and high transfer speeds, optimizing performance and user experience.
Spark Therapeutics uses DoubleClick Floodlight to enhance their digital capabilities and improve operational efficiency.
Spark Therapeutics uses Amazon Web Services to enhance their digital capabilities and improve operational efficiency.
Spark Therapeutics uses PHP to develop dynamic, data-driven web applications and websites, leveraging its robust server-side scripting capabilities for powerful and scalable online experiences.
Spark Therapeutics uses MySQL to store, manage, and retrieve structured data efficiently and reliably, powering scalable web applications and critical business operations with robust data management capabilities.
Spark Therapeutics uses WordPress to enhance their digital capabilities and improve operational efficiency.